Sarepta Therapeutics | هزینه های اجرایی





هزینه های اجرایی تغییر دادن تاریخ
Acadia Pharmaceuticals USD 242.88M 10.68M 2025-09
Agios Pharmaceuticals USD 141.54M 11.8M 2025-12
Alnylam Pharmaceuticals USD 965.32M 84.27M 2025-12
Amgen USD 5.9B 773M 2025-12
BioCryst Pharmaceuticals USD -387.89M 33.7M 2025-09
Biogen USD 1.88B 81.4M 2025-09
BioMarin Pharmaceutical USD 807.82M 259.3M 2025-09
Capricor Therapeutics USD 24.98M 6.15M 2025-03
Daiichi Sankyo JPY 468.57B 15.34B 2025-12
Eli Lilly USD 10.31B 1.09B 2025-12
Esperion Therapeutics USD 67.66M 3.6M 2024-09
Gilead Sciences USD 4.96B 707M 2025-12
Incyte USD 1.12B 3.53B 2025-12
Insmed USD 403.69M 42.4M 2025-09
Ionis Pharmaceuticals USD 316.9M 4.69M 2025-09
Moderna USD 1.54B 259M 2025-12
Nektar Therapeutics USD 85.09M 109.3M 2025-09
Neurocrine Biosciences USD 577.6M 22M 2025-12
Novavax USD 218.53M 34.86M 2024-09
Pfizer USD 12.91B 79.89B 2025-12
PTC Therapeutics USD 207.52M 6.21M 2025-09
Regeneron Pharmaceuticals USD 2.99B 27.97B 2025-12
Roche Holding CHF 21.01B 10.84B 2025-12
Sangamo BioSciences USD 33.87M 12.89M 2024-06
Sanofi EUR 10.51B 1.21B 2025-12
Sarepta Therapeutics USD 462.23M 33.28M 2025-09
Tectonic Therapeutic USD 21.89M 440K 2025-09
Ultragenyx Pharmaceutical USD 321M 9.82M 2025-12
Vertex Pharmaceuticals USD 1.93B 89.1M 2025-12


Sarepta Therapeutics هزینه های اجرایی - ارزش های فعلی، داده های تاریخی، پیش بینی، آمار، نمودار و تقویم اقتصادی - Feb 2026.